Published in J Virol on June 01, 2004
Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77
Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci U S A (2012) 1.72
Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol (2005) 1.56
Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons. J Biol Chem (2010) 1.26
Analysis of human immunodeficiency virus type 1 Gag ubiquitination. J Virol (2005) 1.15
Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog (2011) 1.05
Packaging of actin into Ebola virus VLPs. Virol J (2005) 1.02
Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS Res Hum Retroviruses (2011) 1.01
Cellular kinases incorporated into HIV-1 particles: passive or active passengers? Retrovirology (2011) 0.85
Morphogenesis of the Infectious HIV-1 Virion. Front Microbiol (2011) 0.81
Retroviral env glycoprotein trafficking and incorporation into virions. Mol Biol Int (2012) 0.80
Host-encoded reporters for the detection and purification of multiple enveloped viruses. J Virol Methods (2010) 0.77
Purification of infectious human herpesvirus 6A virions and association of host cell proteins. Virol J (2007) 0.76
Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens. Sci Rep (2016) 0.75
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol (2002) 10.12
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell (1989) 9.68
Form, function, and use of retroviral gag proteins. AIDS (1991) 9.24
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med (2001) 8.38
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell (1993) 7.34
Specific incorporation of cyclophilin A into HIV-1 virions. Nature (1994) 7.13
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) (1991) 7.08
Functional association of cyclophilin A with HIV-1 virions. Nature (1994) 6.82
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell (1996) 6.74
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol (2000) 6.47
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med (2003) 5.97
Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem (1997) 5.58
Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A (2001) 5.46
Macromolecular architecture in eukaryotic cells visualized by cryoelectron tomography. Science (2002) 5.28
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (1992) 5.25
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J Virol (1996) 4.15
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A (2002) 4.14
Three ways to make a vesicle. Nat Rev Mol Cell Biol (2000) 3.98
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology (1997) 3.24
Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol (2001) 2.82
Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J Virol (1999) 2.66
Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol (2002) 2.66
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J (2001) 2.64
Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology (1997) 2.30
Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res Hum Retroviruses (1995) 2.01
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther (2002) 1.95
Cellular proteins in HIV virions. Rev Med Virol (1997) 1.90
Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J Virol (2003) 1.79
A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Biotechnology (N Y) (1994) 1.78
Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62
Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J Virol (2003) 1.43
Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding. J Cell Biol (1996) 1.32
Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography. J Mol Biol (2000) 1.21
The M1 and NP proteins of influenza A virus form homo- but not heterooligomeric complexes when coexpressed in BHK-21 cells. J Gen Virol (1998) 1.20
Further evidence for hexagonal organization of HIV gag protein in prebudding assemblies and immature virus-like particles. J Struct Biol (1998) 1.17
Minimal exclusion of plasma membrane proteins during retroviral envelope formation. Proc Natl Acad Sci U S A (2000) 1.01
Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope. AIDS Res Hum Retroviruses (1999) 0.90
Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner. Virology (1998) 0.88
Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J (2003) 1.93
Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure. Proc Natl Acad Sci U S A (2010) 1.54
Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virus. J Virol (2005) 1.12
The dynamic envelope of a fusion class II virus. Prefusion stages of semliki forest virus revealed by electron cryomicroscopy. J Biol Chem (2006) 1.07
The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization. J Virol (2005) 1.07
Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env. J Virol (2008) 0.99
Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion. J Virol (2003) 0.98
Turning of the receptor-binding domains opens up the murine leukaemia virus Env for membrane fusion. EMBO J (2008) 0.93
Acid-induced movements in the glycoprotein shell of an alphavirus turn the spikes into membrane fusion mode. EMBO J (2002) 0.90
Furin cleavage potentiates the membrane fusion-controlling intersubunit disulfide bond isomerization activity of leukemia virus Env. J Virol (2006) 0.90
Receptor-triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation. J Virol (2006) 0.89
Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering. Proc Natl Acad Sci U S A (2012) 0.89
R-Peptide cleavage potentiates fusion-controlling isomerization of the intersubunit disulfide in Moloney murine leukemia virus Env. J Virol (2007) 0.89
Inhibition of the HIV-1 spike by single-PG9/16-antibody binding suggests a coordinated-activation model for its three protomeric units. J Virol (2013) 0.88
Activation of the alphavirus spike protein is suppressed by bound E3. J Virol (2011) 0.87
Stabilization of TM trimer interactions during activation of moloney murine leukemia virus Env. J Virol (2007) 0.86
The dynamic envelope of a fusion class II virus. E3 domain of glycoprotein E2 precursor in Semliki Forest virus provides a unique contact with the fusion protein E1. J Biol Chem (2008) 0.86
The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase. Virology (2006) 0.86
Cooperative cleavage of the R peptide in the Env trimer of Moloney murine leukemia virus facilitates its maturation for fusion competence. J Virol (2011) 0.84
Proteasomal degradation of core protein variants from chronic hepatitis B patients. J Med Virol (2007) 0.77
Furin cleavage of the Moloney murine leukemia virus Env precursor reorganizes the spike structure. Proc Natl Acad Sci U S A (2014) 0.76
Purification of infectious human herpesvirus 6A virions and association of host cell proteins. Virol J (2007) 0.76
Lectin-mediated retention of p62 facilitates p62-E1 heterodimerization in endoplasmic reticulum of Semliki Forest virus-infected cells. J Virol (2003) 0.75
Translation of hepatitis B virus (HBV) surface proteins from the HBV pregenome and precore RNAs in Semliki Forest virus-driven expression. J Gen Virol (2004) 0.75